Komipharm International Co. Ltd (041960) - Total Liabilities

Latest as of December 2025: ₩61.86 Billion KRW ≈ $41.92 Million USD

Based on the latest financial reports, Komipharm International Co. Ltd (041960) has total liabilities worth ₩61.86 Billion KRW (≈ $41.92 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Komipharm International Co. Ltd - Total Liabilities Trend (2011–2025)

This chart illustrates how Komipharm International Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. See Komipharm International Co. Ltd short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.

Komipharm International Co. Ltd Competitors by Total Liabilities

The table below lists competitors of Komipharm International Co. Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Suncha Technology Co Ltd SHE:001211	China	CN¥1.05 Billion
SIMONA AG O.N. F:SIM0	Germany	€277.41 Million
Auk Corp KO:017900	Korea	₩24.31 Billion
Fagerhult AB ST:FAG	Sweden	Skr6.56 Billion
Super Group Ltd. JSE:SPG	South Africa	ZAC25.13 Billion
Bpost NV BR:BPOST	Belgium	€4.74 Billion
Jumbo Interactive Ltd AU:JIN	Australia	AU$234.44 Million
Rapac Communication & Infrastructure Ltd TA:RPAC	Israel	ILA1.07 Billion

Liability Composition Analysis (2011–2025)

This chart breaks down Komipharm International Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Komipharm International Co. Ltd worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.30	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.89	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.46	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Komipharm International Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Komipharm International Co. Ltd (2011–2025)

The table below shows the annual total liabilities of Komipharm International Co. Ltd from 2011 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩61.86 Billion ≈ $41.92 Million	+8.09%
2024-12-31	₩57.23 Billion ≈ $38.78 Million	-2.31%
2023-12-31	₩58.58 Billion ≈ $39.70 Million	+14.60%
2022-12-31	₩51.12 Billion ≈ $34.64 Million	+4.75%
2021-12-31	₩48.80 Billion ≈ $33.07 Million	+6.93%
2020-12-31	₩45.64 Billion ≈ $30.93 Million	-12.85%
2019-12-31	₩52.37 Billion ≈ $35.49 Million	+12.58%
2018-12-31	₩46.52 Billion ≈ $31.52 Million	-3.09%
2017-12-31	₩48.00 Billion ≈ $32.53 Million	-15.26%
2016-12-31	₩56.64 Billion ≈ $38.38 Million	-1.08%
2015-12-31	₩57.26 Billion ≈ $38.80 Million	-19.62%
2014-12-31	₩71.24 Billion ≈ $48.28 Million	+11.18%
2013-12-31	₩64.08 Billion ≈ $43.42 Million	+75.98%
2012-12-31	₩36.41 Billion ≈ $24.68 Million	+46.34%
2011-12-31	₩24.88 Billion ≈ $16.86 Million	--

About Komipharm International Co. Ltd

KQ:041960 Korea Pharmaceuticals

Market Cap

$338.89 Million

₩500.07 Billion KRW

Market Cap Rank

#14344 Global

#461 in Korea

Share Price

₩8650.00

Change (1 day)

-2.15%

52-Week Range

₩5180.00 - ₩10310.00

All Time High

₩43026.96